Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

PubWeight™: 11.84‹?› | Rank: Top 0.1%

🔗 View Article (PMID 15383478)

Published in Chest on September 01, 2004

Authors

William H Geerts1, Graham F Pineo, John A Heit, David Bergqvist, Michael R Lassen, Clifford W Colwell, Joel G Ray

Author Affiliations

1: Thromboembolism Program, Sunnybrook & Women's College Health Sciences Centre, Room D674, 2075 Bayview Ave, Toronto, ON, Canada M4N 3M5.

Articles citing this

(truncated to the top 100)

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.29

Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood (2008) 4.06

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica (2009) 3.63

The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol (2008) 3.50

A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg (2006) 2.97

Venous thromboembolism in the outpatient setting. Arch Intern Med (2007) 2.46

Evidence based medicine has come a long way. BMJ (2004) 2.42

Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects. Eur J Clin Pharmacol (2005) 2.40

Management of bleeding following major trauma: a European guideline. Crit Care (2007) 2.40

Best practices for elderly hip fracture patients. A systematic overview of the evidence. J Gen Intern Med (2005) 2.27

Risk vs benefits for thromboembolic disease after total joint surgery. Chest (2005) 2.26

Air travel and venous thromboembolism: a systematic review. J Gen Intern Med (2007) 2.21

Venous thromboprophylaxis in UK medical inpatients. J R Soc Med (2005) 2.14

Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol (2006) 1.95

Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study. BMJ (2006) 1.95

Epidemiology and risk factors for venous thrombosis. Semin Hematol (2007) 1.90

Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res (2008) 1.82

Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol (2007) 1.80

Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative. BMJ (2012) 1.78

Risk factors for venous and arterial thrombosis. Blood Transfus (2010) 1.58

Venous thromboembolism-related mortality and morbidity in King Fahd General Hospital, Jeddah, Kingdom of Saudi Arabia. Ann Thorac Med (2011) 1.56

Early acute management in adults with spinal cord injury: a clinical practice guideline for health-care professionals. J Spinal Cord Med (2008) 1.54

[Austrian Guidelines for Prophylaxis of Venous Thromboembolism]. Wien Klin Wochenschr (2007) 1.51

Compliance with Surgical Care Improvement Project measures and hospital-associated infections following hip arthroplasty. J Bone Joint Surg Am (2012) 1.50

Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review. Pharmacoeconomics (2010) 1.46

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. Br J Cancer (2010) 1.46

Thromboembolic complications of sling surgery for stress urinary incontinence among female Medicare beneficiaries. Urology (2009) 1.41

Direct oral anticoagulants: integration into clinical practice. Postgrad Med J (2014) 1.40

Prevention of hospital-acquired thrombosis from a primary care perspective: a qualitative study. Br J Gen Pract (2016) 1.38

Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Res Notes (2010) 1.36

Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study. Arch Intern Med (2008) 1.36

The Prophylaxis of Venous Thromboembolism. Dtsch Arztebl Int (2016) 1.36

Venous thromboembolic disease and cancer. Postgrad Med J (2006) 1.23

Inflammation and the host response to injury a large-scale collaborative project: patient-oriented research core standard operating procedure for clinical care X. Guidelines for venous thromboembolism prophylaxis in the trauma patient. J Trauma (2008) 1.20

Rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--has no clinically relevant interaction with naproxen. Br J Clin Pharmacol (2006) 1.18

Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review. CMAJ (2005) 1.18

Factors affecting perioperative blood loss and transfusion rates in primary total joint arthroplasty: a prospective analysis of 1642 patients. Can J Surg (2009) 1.18

Prolonged work- and computer-related seated immobility and risk of venous thromboembolism. J R Soc Med (2010) 1.15

Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process. J Gen Intern Med (2007) 1.11

Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis: implications for novel intervention strategies. PLoS One (2013) 1.08

Postdischarge thromboprophylaxis and mortality risk after hip-or knee-replacement surgery. CMAJ (2008) 1.07

Venous thromboembolism and survival in patients with high-grade glioma. Neuro Oncol (2007) 1.07

Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? J Arthroplasty (2009) 1.07

Addressing the sociotechnical drivers of quality improvement: a case study of post-operative DVT prophylaxis computerised decision support. BMJ Qual Saf (2011) 1.04

Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients. Int Orthop (2007) 1.03

Thromboembolic events with lenalidomide-based therapy for multiple myeloma. Cancer (2008) 1.03

Pulmonary embolism as a complication of major depressive disorder with catatonic features: a case report. Psychiatry (Edgmont) (2007) 1.03

Risk factors for pulmonary embolism after hip and knee arthroplasty: a population-based study. Int Orthop (2008) 1.03

Cerebral venous sinus thrombosis in an adolescent with Ewing sarcoma. Childs Nerv Syst (2008) 1.00

Korean guidelines for the prevention of venous thromboembolism. J Korean Med Sci (2010) 0.99

Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study. Arthritis Res Ther (2014) 0.99

Thromboprophylaxis in spinal surgery: a survey. J Orthop Surg Res (2012) 0.99

Predictors of venous thromboembolism in patients with advanced common solid cancers. J Cancer Epidemiol (2010) 0.98

Learning to predict post-hospitalization VTE risk from EHR data. AMIA Annu Symp Proc (2012) 0.98

Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009). Am J Med (2014) 0.98

Venous thromboembolism in medical inpatients--the silent epidemic of neglect. J R Soc Med (2005) 0.97

Duration of hospital participation in a nationwide stroke registry is associated with improved quality of care. BMC Neurol (2006) 0.96

Clinical review: Critical care management of spontaneous intracerebral hemorrhage. Crit Care (2008) 0.96

Sudden death caused by acute pulmonary embolism after laparoscopic total extraperitoneal inguinal hernia repair: a case report and literature review. Hernia (2017) 0.96

Cancer-associated thrombosis: prevention and treatment. Curr Oncol (2008) 0.95

Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants. Thromb J (2011) 0.95

Retrospective analysis of the use of inferior vena cava filters in routine hospital practice. Postgrad Med J (2006) 0.93

Is routine thromboprophylaxis justified among Indian patients sustaining major orthopedic trauma? A systematic review. Indian J Orthop (2011) 0.93

Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis Evidence-based Clinical Practice Guidelines. J Korean Med Sci (2014) 0.92

Little impact of antiplatelet agents on venous thromboembolism after hip fracture surgery. J Korean Med Sci (2011) 0.92

The effect of postoperative enoxaparin on risk for reoperative hematoma. Plast Reconstr Surg (2012) 0.92

Factor V-Leiden Mutation: A Common Risk Factor for Venous Thrombosis among Lebanese Patients. Thrombosis (2012) 0.91

Vena cava filters in spinal cord injuries: evolving technology. J Spinal Cord Med (2006) 0.91

Venous thromboembolism in Korean patients undergoing major orthopedic surgery: a prospective observational study using computed tomographic (CT) pulmonary angiography and indirect CT venography. J Korean Med Sci (2009) 0.91

Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population. Eur J Clin Pharmacol (2013) 0.90

Venous thromboembolism after spinal cord injury. Arch Phys Med Rehabil (2009) 0.90

Utility of once-daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multisystem trauma patients. World J Surg (2007) 0.90

Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery. Clin Orthop Relat Res (2010) 0.89

Retrospective comparison of three thromboprophylaxis agents, edoxaban, fondaparinux, and enoxaparin, for preventing venous thromboembolism in total knee arthroplasty. Int Orthop (2013) 0.89

Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgery. J Am Coll Surg (2011) 0.89

In-hospital death following inpatient surgical procedures in the United States, 1996-2006. World J Surg (2011) 0.88

Are There Any Differences in the Clinical and Economic Outcomes Between US Cancer Patients Receiving Appropriate or Inappropriate Venous Thromboembolism Prophylaxis? J Oncol Pract (2009) 0.88

Discontinuation of warfarin is unnecessary in total knee arthroplasty. Clin Orthop Relat Res (2010) 0.88

Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins. Curr Drug Targets (2013) 0.87

Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery. Vasc Health Risk Manag (2006) 0.87

Risk of Thromboembolism Following Body-Contouring Surgery After Massive Weight Loss. Eplasty (2015) 0.87

Prophylactic and therapeutic anticoagulation for thrombosis: major issues in oncology. Nat Clin Pract Oncol (2008) 0.87

Symptomatic venous thromboembolism is a disease related to infection and immune dysfunction. Int J Med Sci (2012) 0.87

Resource consumption and management associated with monitoring of warfarin treatment in primary health care in Sweden. BMC Fam Pract (2006) 0.87

A randomized-clinical trial examining a neoprene abdominal binder in gynecologic surgery patients. Clin Exp Obstet Gynecol (2014) 0.87

Management of Deep Vein Thrombosis (DVT) Prophylaxis in Trauma Patients. Bull Emerg Trauma (2016) 0.86

Patients' instability, emergency response, and outcomes in the radiology department. Am J Crit Care (2011) 0.86

Clinically important deep vein thrombosis in the intensive care unit: a survey of intensivists. Crit Care (2004) 0.86

Safety, pharmacokinetics and pharmacodynamics of single/multiple doses of the oral, direct Factor Xa inhibitor rivaroxaban in healthy Chinese subjects. Br J Clin Pharmacol (2009) 0.86

Deep vein thrombosis and thromboprophylaxis in arthroscopic anterior cruciate ligament reconstruction. Indian J Orthop (2011) 0.86

Differences in perioperative care at low- and high-mortality hospitals with cancer surgery. Ann Surg Oncol (2014) 0.86

Prevention of venous thromboembolism in hospitalized patients with cancer. J Clin Oncol (2009) 0.85

Guidelines for deep venous thrombosis prophylaxis during laparoscopic surgery. Surg Endosc (2007) 0.85

Dutch orthopedic thromboprophylaxis: a 5-year follow-up survey. Acta Orthop (2009) 0.85

Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients. Thromb J (2006) 0.85

Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplasty. Can J Surg (2011) 0.85

Post-discharge symptomatic thromboembolic events in hip fracture patients. Ann R Coll Surg Engl (2007) 0.85

Thrombotic complications following liver resection for colorectal metastases are preventable. HPB (Oxford) (2008) 0.84

Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations. World J Surg (2016) 0.84

Inflammation, TNFα and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemia. Am J Hematol (2011) 0.84

Articles by these authors

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet (2009) 6.83

Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55

Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24

Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13

Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA (2009) 6.06

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.99

Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med (2012) 5.25

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet (2007) 4.99

Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med (2010) 4.77

Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol (2005) 4.39

Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 4.30

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med (2003) 3.96

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med (2002) 3.96

Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med (2003) 3.85

Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology (2003) 3.83

Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68

Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost (2007) 3.67

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ (2006) 3.58

The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genet Epidemiol (2010) 3.48

The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study*. Crit Care Med (2014) 3.29

Bias in published cost effectiveness studies: systematic review. BMJ (2006) 2.60

Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors. Kidney Int (2013) 2.42

Proliferation of prenatal ultrasonography. CMAJ (2010) 2.33

Correlation between the knee adduction torque and medial contact force for a variety of gait patterns. J Orthop Res (2007) 2.27

Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet (2002) 2.26

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med (2003) 2.22

Estimating the prevalence of renal insufficiency in seniors requiring long-term care. Kidney Int (2004) 2.09

Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol (2007) 2.06

Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation. Mayo Clin Proc (2008) 1.97

[Screening for abdominal aortic aneurysm saves lives at a reasonable cost]. Lakartidningen (2003) 1.96

Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol (2006) 1.95

Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. CMAJ (2010) 1.95

Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial. Stroke (2009) 1.94

Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther (2003) 1.91

Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med (2006) 1.88

Prevention of venous thromboembolism. Chest (2005) 1.76

In vivo knee loading characteristics during activities of daily living as measured by an instrumented total knee replacement. J Orthop Res (2008) 1.73

Cost-effectiveness of different screening strategies for abdominal aortic aneurysm. J Vasc Surg (2005) 1.72

Preeclampsia as a risk factor for diabetes: a population-based cohort study. PLoS Med (2013) 1.69

Polyethylene wear and acetabular component orientation. J Bone Joint Surg Am (2003) 1.62

Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels. Mayo Clin Proc (2011) 1.62

Methodology for isolation, identification and characterization of microvesicles in peripheral blood. J Immunol Methods (2011) 1.58

Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am J Hematol (2005) 1.56

Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med (2010) 1.55

Tibial forces measured in vivo after total knee arthroplasty. J Arthroplasty (2006) 1.51

Haemostatic markers in patients with abdominal aortic aneurysm and the impact of aneurysm size. Thromb Res (2009) 1.51

Iatrogenic vascular injuries in varicose vein surgery: a systematic review. World J Surg (2007) 1.49

Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res (2006) 1.48

Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia. Am J Obstet Gynecol (2011) 1.47

Decreased knee adduction moment does not guarantee decreased medial contact force during gait. J Orthop Res (2010) 1.45

Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol (2008) 1.44

Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol (2008) 1.44

The potential role of fondaparinux as venous thromboembolism prophylaxis after total hip or knee replacement or hip fracture surgery. Arch Intern Med (2002) 1.44

Disequilibrium between admitted and discharged hospitalized patients affects emergency department length of stay. Ann Emerg Med (2009) 1.44

Press-fit condylar design total knee arthroplasty. Fourteen to seventeen-year follow-up. J Bone Joint Surg Am (2007) 1.42

Economic evaluation of decompressive craniectomy versus barbiturate coma for refractory intracranial hypertension following traumatic brain injury. Crit Care Med (2014) 1.42

Long-term survival after carotid endarterectomy for asymptomatic stenosis. Stroke (2006) 1.41

[Diagnosis of acute pulmonary embolism. Simplified strategy based on clinical probability, D-dimer and computer tomography]. Lakartidningen (2006) 1.40

[Symptomatic carotid stenosis should be treated surgically, not with stenting. Great risks with stents, according to studies]. Lakartidningen (2007) 1.39

[Electromagnetic therapy of circulatory disorders in the lower extremities. Promising advertisements in daily press are not scientifically documented]. Lakartidningen (2005) 1.38

An implantable telemetry device to measure intra-articular tibial forces. J Biomech (2005) 1.38

In vivo medial and lateral tibial loads during dynamic and high flexion activities. J Orthop Res (2007) 1.38

[A promising start for quality indicator work within vascular surgery?]. Lakartidningen (2002) 1.38

A multiaxial force-sensing implantable tibial prosthesis. J Biomech (2006) 1.35

Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum (2012) 1.34

A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg (2007) 1.33

Incidence of 'squeaking' after ceramic-on-ceramic total hip arthroplasty. Clin Orthop Relat Res (2010) 1.32

Phenotype harmonization and cross-study collaboration in GWAS consortia: the GENEVA experience. Genet Epidemiol (2011) 1.29

Effective gait patterns for offloading the medial compartment of the knee. J Orthop Res (2009) 1.28

Can normal knee kinematics be restored with unicompartmental knee replacement? J Bone Joint Surg Am (2005) 1.26

Identifying in-hospital venous thromboembolism (VTE): a comparison of claims-based approaches with the Rochester Epidemiology Project VTE cohort. Med Care (2008) 1.24

In vivo knee moments and shear after total knee arthroplasty. J Biomech (2007) 1.24

Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med (2002) 1.23

Tracheostomy timing in traumatic brain injury: a propensity-matched cohort study. J Trauma Acute Care Surg (2014) 1.22

Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23 796 consecutive autopsies. Eur Heart J (2005) 1.19

Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis (2009) 1.18

Increasing incidence of ruptured abdominal aortic aneurysm: a population-based study. J Vasc Surg (2006) 1.18

The Chitranjan Ranawat Award: in vivo knee forces after total knee arthroplasty. Clin Orthop Relat Res (2005) 1.17

Risk factors associated with abdominal aortic aneurysm: a population-based study with historical and current data. J Vasc Surg (2005) 1.15

Prevention and detection of diabetic embryopathy. Community Genet (2002) 1.14

Risk of chronic dialysis and death following acute kidney injury. Am J Med (2012) 1.12

Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk. J Cardiovasc Transl Res (2011) 1.11

The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001--summary and conclusions. Acta Oncol (2003) 1.11

Bony impingement affects range of motion after total hip arthroplasty: A subject-specific approach. J Orthop Res (2008) 1.10

Oxidized zirconium femoral components reduce polyethylene wear in a knee wear simulator. Clin Orthop Relat Res (2004) 1.09